Replication of these findings in other populations and identifying mechanisms underlying the single nucleotide polymorphism and activating agents would provide better understanding of scope of the impact on obesity and the significance if any for development of therapeutics targeting PAR2. Here, F2RL1 is linked to obesity due to melanocortin 4 receptor deficiency.